XML 28 R5.htm IDEA: XBRL DOCUMENT v3.22.4
Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Secondary Offering
At-the-market offering
Common Stock
Common Stock
Secondary Offering
Common Stock
At-the-market offering
Additional Paid-In Capital
Additional Paid-In Capital
Secondary Offering
Additional Paid-In Capital
At-the-market offering
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2020 $ 321,220     $ 3     $ 439,235     $ (118,021) $ 3
Beginning Balance, Shares at Dec. 31, 2020       32,627,963              
Vesting of shares of common stock subject to repurchase 35           35        
Vesting of shares of common stock subject to repurchase, Shares       62,045              
Issuance of common stock upon exercise of stock option 1,479           1,479        
Issuance of common stock upon exercise of stock option , Shares       281,099              
Share-based compensation expense 14,461           14,461        
Unrealized loss on short-term investments (153)                   (153)
Net loss (86,075)                 (86,075)  
Ending Balance at Dec. 31, 2021 250,967     $ 3     455,210     (204,096) (150)
Ending Balance, Shares at Dec. 31, 2021       32,971,107              
Issuance of common stock upon secondary offering, net of issuance costs   $ 215,334 $ 1,559   $ 2     $ 215,332 $ 1,559    
Issuance of common stock upon secondary offering, net of issuance costs, Shares       113,213 15,333,334 113,213          
Vesting of shares of common stock subject to repurchase 15           15        
Vesting of shares of common stock subject to repurchase, Shares       15,278              
Issuance of common stock upon exercise of stock option 1,397           1,397        
Issuance of common stock upon exercise of stock option , Shares       383,120              
Issuance of common stock upon employee stock purchase plan 445           445        
Issuance of common stock upon employee stock purchase plan,share       61,754              
Share-based compensation expense 16,856           16,856        
Unrealized loss on short-term investments (529)                   (529)
Net loss (113,837)                 (113,837)  
Ending Balance at Dec. 31, 2022 $ 372,207     $ 5     $ 690,814     $ (317,933) $ (679)
Ending Balance, Shares at Dec. 31, 2022       48,877,806